Our aim in this project was to assess the variability of and explore the evidence supporting local protocols and national policies developed and used by providers of routine antenatal care in Australia. This report focuses on the results for six aspects of antenatal care: the number of routine visits; screening for gestational diabetes, syphilis, hepatitis C, and HIV; and the provision of information and advice about smoking cessation. These six areas were chosen because each is the subject of current debate or interest. They illustrate rather than exhaustively describe the many elements of antenatal care that may be considered routine.
METHODS

1.Methods
Public hospitals and Divisions of General Practice were contacted by telephone or email between November 1999 and March 2000. In each State and Territory, all Divisions of General Practice and all hospitals with more than 200 births each year were contacted, as well as some hospitals having fewer births. Protocols for routine antenatal care were requested from each organisation. Information was also sought from hospitals about birthing and antenatal care services provided.
All information sent by each organisation was included as one "protocol". Recommendations about specific areas of antenatal care were identified in each protocol and entered into a database. Excel 7 was used for collation and to calculate the proportions of protocols making specific recommendations. Recommendations about screening were classified as "universal", "selective" or "unclear". If a test was included on a checklist, clinical record or form with-
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It was not feasible to conduct systematic reviews for each content area. Instead, we searched for evidence supporting recommendations, and any current debates. MEDLINE, the Cochrane Library, 9 the Database of Abstracts of Reviews of Effectiveness (DARE) 10 and the Turning Research into Practice (TRIP) database 11 were searched to identify systematic reviews. A guide to effective care in pregnancy and childbirth 12 was a major secondary source of evidence.
RESULTS
1.Results
Of 227 selected hospitals, 225 were contacted. Birthing and antenatal care services were provided by 218 (97%) and 125 (56%) contacted hospitals, respectively. Of hospitals with more than 200 births per year, the proportions providing antenatal care were less in Victoria (39%) and South Australia (43%) than in Western Australia (57%) and New South Wales (60% Protocols varied widely in format and quantity of information, and included checklists, guidelines, clinical records or forms, and information designed for women as well as for practitioners. References to research papers or other sources of evidence were very infrequent.
Recommendations in the protocols
Number of routine visits
Eighty protocols (75%) included a recommendation about the number and timing of visits for routine antenatal care. A "standard" schedule of antenatal visits was frequently referred to as every four weeks until 28 weeks' gestation, then every two weeks until 36 weeks, then every week until 40 weeks or delivery. Most protocols (63; 79% of those covering the issue) recommended this standard schedule. Fewer visits or a more flexible approach were described in 12 protocols (15%), and extra routine visits, all relating to shared-care arrangements, were recommended in five (6%).
Screening for gestational diabetes
Most protocols (96; 90%) included a recommendation about screening for gestational diabetes mellitus (GDM): 78 protocols (81% of those covering the issue) recommended universal testing, 15 (16%) recommended testing specific groups of women only, and three (3%) had unclear recommendations. Protocols involving tertiary hospitals were more likely to recommend selective testing (29%) than non-tertiary-hospital protocols (13%). No protocols recommended against screening for GDM.
Testing was most commonly (80% of protocols) recommended at gestation between 26 and 28 weeks.
Screening tests recommended in different protocols most commonly included glucose challenge and tolerance tests, as well as HbA 1c and random blood sugar levels. Different names were used for glucose challenge and tolerance tests in different protocols, and in some cases the same term was used to describe different tests. For example, the term "modified glucose tolerance test" was used in different protocols to describe a 50 g one-hour test and a 75 g two-hour test.
Screening for syphilis
Most protocols (98; 92%) included a recommendation about screening for syphilis: 93 (95% of these protocols) recommended testing all women at the first visit. The remaining protocols were unclear, and no protocols recommended against testing.
Screening for HIV
Just over half the protocols (59; 55%) included a recommendation about HIV screening. Of these, 33 (56%) recommended testing selected groups of women for HIV. This included 67% of protocols involving tertiary hospitals, and 54% of those not involving tertiary hospitals. The remaining 26 protocols (44% of protocols covering the issue) recommended testing all women for HIV.
Screening for hepatitis C virus
About half the protocols (52; 49%) included a recommendation about hepatitis C virus (HCV) screening. Of these, 32 (62%) recommended testing selected groups of women for HCV. These included 91% of protocols involving tertiary hospitals and 55% of those not involving tertiary hospitals. The remaining 20 protocols (40%) recommended testing all women for HCV.
Smoking cessation
Most protocols (96; 90%) did not include written information and advice about smoking cessation, although 30 of these protocols (28% of the total sample) included smoking as an item on a checklist. Of the 11 protocols including written information and advice, only
MJA
Vol 176
18 March 2002 257 RESEARCH two gave comprehensive details of how women could best be advised and supported in quitting smoking.
National policies
Identified national policies and guidelines are summarised in the Box.
DISCUSSION
1.Discussion
Almost all public hospitals providing antenatal care reported having some form of protocol for routine care. However, protocols obtained from public hospitals and Divisions of General Practice varied substantially in their form and content. More importantly, specific recommendations often differed and were not consistent with existing national guidelines.
Number of routine antenatal care visits
The source of Australia's predominant "standard" schedule is a 1929 policy statement from the United Kingdom, 16 and its continued currency in Australia 70 years later is surprising. A recent systematic review by the World Health Organization concluded that reduced schedules of visits are not associated with worse outcomes for mothers or babies. 17 Some trials found women to be less satisfied with schedules of less frequent visits. Although this finding is of concern, women's experiences will be influenced by the expectations of women and providers about what is "standard". 18 Approaches with fewer prescribed visits could offer women more flexibility in antenatal care, and may become a new standard.
Screening for GDM
Although most Australian providers of antenatal care recommend screening for GDM, this practice remains controversial. Advocates of screening most frequently cite reports of associations between a diagnosis of GDM and increased frequencies of adverse outcomes for women or babies. 13, 19 However, the many other possible explanations for these associations mean the contribution of GDM as a "cause" of adverse outcomes remains contentious. 12, 20 Improved outcomes for women or babies attributed to screening for and managing GDM have not been clearly demonstrated. 21, 22 In addition, labelling women as "high risk" during and after pregnancy, giving prescriptive advice about diet and exercise, and managing women with insulin may each have adverse effects. 12, 21 The national guidelines and protocols reviewed here, and Australian hospital practices reported elsewhere, 23 recommend many different specific approaches to screening for GDM. There is a need for a comprehensive systematic review of the evidence regarding screening for GDM to better inform policy and practice in Australia.
Screening for syphilis
For syphilis screening, there was concordance between recommendations in the protocols, a national policy, and research evidence. A systematic review evaluating all aspects of antenatal screening for syphilis was recently conducted in the UK in response to concerns about the cost effectiveness of screening for a condition of very low prevalence. 24 In recommending the continuation of universal screening, the review highlighted the availability of simple, safe and effective treatment, the small potential gain in resources from stopping screening, and the likely ineffectiveness and unacceptability of targeted screening.
Screening for HIV
Effective intervention to reduce vertical transmission of HIV was first reported in 1994, and good evidence of the effectiveness of treatment and other management strategies has accumulated since then. 25 In Australia, HIV is uncommon among pregnant women. Consequently, HIV testing, although having very high specificity, might result in some false-positive and indeterminate results. 15, 26 Although women are generally accepting of antenatal HIV testing, 27 the process of testing and indeterminate or false-positive test results may have negative psychosocial effects.
The merits of different approaches to antenatal screening for HIV are being debated in Australian and international publications. [28] [29] [30] Antenatal testing of all pregnant women is increasingly promoted in Australia and other affluent countries, prompted by concern about persistent reports of vertical transmisAustralian national policies or guidelines about specific aspects of antenatal care
Number of routine visits No national guidelines identified. Screening for gestational diabetes mellitus Australian Diabetes in Pregnancy Society: "Universal screening is recommended. If selective screening is considered more appropriate (because of limited resources or known low GDM incidence), screening may be reserved for those at higher risk." 13 RANZCOG "does not currently recommend routine screening of all antenatal patients". 8 Screening for syphilis RANZCOG: Syphilis serology is listed as a routine screening test. 8 Screening for HCV RANZCOG: "All pregnant women with a significant risk factor for HCV should be screened." 8 NHMRC: ". . . antenatal screening for HCV infection should be confined only to those women who provide a history of risk factors, or request screening when counselled about relevant risk." 14 Screening for HIV RANZCOG recommends "that screening be offered to all pregnant women, but only after appropriate counselling is given." 
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Informed consent is particularly relevant in the context of a trend towards universal testing for HIV during pregnancy. Antenatal tests considered "routine" can be presented to women without adequate information or real opportunities to refuse testing. 31 Current best practice for HIV testing in Australia requires that any person have enough information, and the opportunity, to choose whether they are tested. 15 The extent to which this is reflected in practice in Australian antenatal settings remains unclear.
Screening for HCV
That 40% of reviewed protocols recommended universal testing of pregnant women for HCV is of concern. The two national policies recommend selective testing, 8, 14 and no published reports were found in support of universal antenatal HCV testing. The risk of vertical transmission of hepatitis C is estimated as 6% if a woman is HCV RNA positive, and negligible if she is HCV RNA negative. 32 There are currently no interventions that reduce the risk of transmission of HCV from mother to baby. A diagnosis of HCV can result in significant psychosocial morbidity. Stigmatisation and discrimination, including by health service staff, are commonly reported for people who are HCV positive. 33 If nothing can be done to improve outcomes, during pregnancy may not be the best time for a woman to have an HCV test, nor to find out she is HCV positive.
Smoking cessation
There is good evidence that smokingcessation programs during pregnancy can be effective in assisting women to stop smoking, and in reducing low birth weight and preterm birth rates. 34 That smoking cessation was not mentioned in most of the protocols suggests that an effective intervention is not being promoted as part of routine antenatal care. It is possible that separate protocols dealt with the issue of smoking in pregnancy. However, other studies confirm significant barriers to smoking cessation being adopted as a priority issue by many antenatal care providers in Australia. 35, 36 Although no Australian national policy or guidelines about smoking cessation in pregnancy were identified, a 1999 national consensus conference endorsed their development. 37 Our results indicate a need for this policy and other strategies to encourage providers to include smoking-cessation programs as part of routine antenatal care.
CONCLUSIONS
1.Conclusions
Routine antenatal care involves many more content areas than are considered here. For each Australian organisation providing antenatal care to undertake systematic reviews of research evidence in each area would be unrealistic, and an inefficient use of resources. In Victoria, three tertiary maternity hospitals have combined resources to develop evidence-based consensus guidelines, aiming to standardise routine antenatal care in these institutions. 38 Extending this effort nationally to produce and disseminate systematic reviews of research evidence and practice guidelines could assist local providers of care to develop evidence-based protocols for practitioners and women, and reduce the inconsistencies in recommended antenatal care. The existence of guidelines and protocols does not guarantee effective and appropriate care. However, it seems likely that a substantial effort to increase the access of practitioners and women to information about the best available evidence would aid this quest.
